Three Unconvincing Profitable Stocks: Q2 Holdings, ANI Pharmaceuticals, and BNY

Q2 Holdings (QTWO) has a 5% GAAP operating margin, with underwhelming ARR growth and estimated sales growth of 10.3% for the next 12 months. ANI Pharmaceuticals (ANIP) has a 12.6% GAAP operating margin, but a modest revenue base and decreased efficiency over the last two years. BNY (BK) has a 36.1% GAAP operating margin, but its valuation ratio is not provided.